Effects of diphenyl derivatives on electrophoretic mobility of murine T lymphocytes
Dolga OV1, Pogoriela NKh1, Bohorad-Kobel's'ka OS2, Zholobak NM2, Zanoza SO3, Liakhov SA3, Mahura IS1
- О.О. Bogomoletz Institute of Physiology National Academy of Sciences of Ukraine, Kyiv, Ukraine
- D.K. Zabolotny Institute of microbiology and virology National Academy of Sciences of Ukraine, Kyiv, Ukraine
- O.V. Bogatsky Physicо-Chemiсal Institute National Academy of Sciences of Ukraine, Odesa, Ukraine
DOI: https://doi.org/10.15407/fz59.03.031
Abstract
The early changes of electrophoretic mobility (EPM) of murine T lymphocytes induced by structural analogues of amixine-dihydrochloryde 4,4'-bis-[2(diethylamino)ethoxy]diphenyl (compound 1) and dihydrochloryde 2-methoxycarbonil-4,4'-bis-[2(diethylamino)ethoxy]diphenyl (compound 2) were studied by electrophoresis technique. During the interval 0-2 hours all compounds increased the absolute values of EPM in comparison with control. These changes were of the same kind--distinctions were quantitative. Amixine and compound 1 during the interval 2-4 hours additionally increased the EPM. The compound 2, on the contrary, decreased the EPM. It was shown that the opposite effects of the aforementioned compounds were caused by the fact that amixine and compound 1 induce, and compound 2 does not induce IFN production in T lymphocytes in vitro. The results of our experiments are important for understanding of the mechanisms of immunomodulating effect of amixine and its structural analogues.
Keywords:
amixine, diphenyl derivatives, interferon inducers,T lymphocytes, electrophoretic mobility
References
- Bogats'kii O.V., Gren' A.I., Litvinova L.O., LempartG.V. Pro sintez 2,7-bis-[2-(dietilamino)etoksi]-fluoren-9-onu . Dop. AN URSR. Ser. B. 1976. N 7. P. 610-612 .
- Grinshtein S.V., Kost O.A. Strukturno-funktsional'-nie osobennosti membrannih belkov . Uspehi biol.himii. 2001. 41. P. 77-104.
- Dolga O.V., Zholobak N.M., Spivak M.Ya., Magura I.S.Vpliv ?/?-interferonu na elektroforetichnu ruho-mist' T-limfotsitiv mishi . Fiziol. zhurn. 2009. 55,N 1. P. 7-11.
- Dolgaya E.V., Krilova I.V., Rozhmanova O.M. Izmenenieelektroforeticheskoi podvizhnosti T-limfotsitovmishi pod vliyaniem konkanavalina A . Biol. memb-rani. 1991. 8, N 7. P. 755-762.Vpliv pohidnih difenilu na elektroforetichnu ruhomist' t-limfotsitivISSN 0201-8489 Fiziol. zhurn., 2013, T. 59, N 3 37
- Ershov F.I., Kiselev O.I. Interferoni i ih induk-tori (ot molekul do lekarstv). M.: GOETAR-Media,2005. 368 p.
- Lyahov S.A., Litvinova L.A. Mehanizmi protivovi-rusnoi aktivnosti Amiksina (obzor literaturi) 1.Obshchaya harakteristika i induktsiya interferona .Suchasni infektsii. 2007. N 4. P. 99-105.
- Lyahov S.A., Litvinova L.A. Mehanizmi protivovi-rusnoi aktivnosti Amiksina (obzor literaturi)(Prodolzhenie) . Tam samo. 2008. N 1. P. 82-86.
- Lyahov S.A., Litvinova L.A. Mehanizmi protivovi-rusnoi aktivnosti amiksina (obor literaturi). 2.Protivovirusnaya aktivnost' i vliyanie na nekotoriebiohimicheskie protsessi . Tam samo. 2008. N 2. P.112-116.
- Lyahov S.A., Litvinova L.A. Mehanizmi protivovi-rusnoi aktivnosti amiksina (obzor literaturi). 2.Protivovirusnaya aktivnost' i vliyanie na nekotoriebiohimicheskie protsessi . Tam samo. 2008. 3. P. 89-95.
- Petrov R.V., Ataullahanov R.I. Biohimiya membran.Kletochnie membrani i immunitet. M.:Vissh. shkola,1991. 144 p.
PubMedCentral
- Hant S. Videlenie limfotsitov i vspomogatel'nihkletok. V kn.: Limfotsiti. Metodi. Red. Dzh. Klaus,per. s angl. M.: Mir, 1990. P. 15-68.
- Shai D.S., Zholobak N.M., Lyahov S.A., Mal'tsev G.V.,Fernandes de Rivas S.O., Litvinova L.O., AndronatiS.A., Spivak M.Ya. Interferonogenna aktivnist'analogiv amiksinu i pohidnih difenilu . Mikrobiol.zhurn. 2007. 69, N 5. P. 59-64.
- Shai D.S., Zholobak N.M., Spivak M.Ya. Stan sistemiinterferonu u mishei, obroblenih amiksinom ta iogoanalogami . Imunologiya ta alergologiya. 2007. N 1. P. 22-23.
- Ekkert R. Razdelenie kletok immunnoi sistemi. Vkn.: Immunologicheskie metodi. Red. Frimel' G., per.s nem. M.: Mir, 1987. P. 226-253.
- Alcaro S., Arena A., Di Bella R., Neri S., Ottana R., OrtusoF., Pavone B., Vigorita M.G. 9fluorenon-4-carboxamides:synthesis, conformational analysis, anti-HSV-2, andimmunomodulatory evaluation. Note II . ARKIVOC 2004. 5 P. 334-348.
- Alcaro S., Arena A., Di Bella R., Neri S., Ottana R., OrtusoF., Pavone B., Trincone A., Vigorita M.G. Biocatalysedsynthesis of ?-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2properties . Bioorganic & Med. Chem. 2005. 13,N 10. P. 3371-3378.
CrossRef
PubMed
- Arena A., Arena N., Ciurleo R., De Gregorio A., MaccariR., Ottana R., Pavone B., Tramice A., Trincone A., VigoritaM.G. 2/4-substituted-9-fluorenones and their O-glucosidesas potential immunomodulators and anti-herpes simplexvirus-2 agents. Part 5 . Europ. J. Med. Chem. 2008. 43,N 12. P. 2656-2664.
CrossRef
PubMed
- Bogorad-Kobelska O.S., Zholobak N.M., Dolga O.V.Maltzev G.V., Lyakhov S.A., Andronati S.A., SpivakM.Ya. Diphenyl derivatives: cytotoxicity, antiviral andIFN-inducing activities in vitro . IJBM. 2011. 1,N 3. P. 153-157.
- Borden E.C., Sen G.C., Uze G., Silverman R.H., RansohoffR.M., Foster G.R., Stark G.R. Interferons at age 50: past,current and future impact on biomedicine . Nature Rev.2007. 6, December. P. 975-990.
CrossRef
- Bredehorn T., Duncker G.I. Tilorone-induced functionalchanges in the rat retina . Klin. Monatsbl. Augenheilkd.2000. 216, N 4. P. 219-222.
CrossRef
PubMed
- Briggs C.A., Schrimpf M.R., Anderson D.J., Gubbins E.J.,Gronlien J.H., Hakerud M., Ween H., Thorin-Hagene K.,J., Li J., Bunnelle W.H., Gopalakrishnan M., MeyerM.D. Alpha7 nicotinic acetylcholine receptor agonistproperties of tilorone and related tricyclic analogues. Brit. J. Pharmacol. 2008. 153, N 5. P. 1054-1061.
CrossRef
PubMed PubMedCentral
- Chandra P. Tilorone hydrochloride: the drug profile . Top.Curr. Chem. 1977. 72, N 1. P. 125-148.
CrossRef
PubMed
- Dolga O.V., Pogorela N. Kh., Bogorad-Kobelska O.S.,Andronati S.A., Magura I.S. Effect of amixine onelectrophoretic mobility of murine T lymphocytes . Int.J. Physiol. Pathophysiol. 2011. 2, N 4. P. 355-360.
CrossRef
- Feldmann M. Many cytokines are very useful therapeutictargets in disease . J. Clin. Invest. 2008. 118, N 11.P. 3533-3536.
CrossRef
PubMed PubMedCentral
- Fischer J., Lullmann H., Lullmann-Rauch R. Drug-inducedlysosomal storage of sulphated glycosaminoglycans. General. Pharmacol. The Vascular System. 1996. 7,N 8. P. 1317-1324.
CrossRef
- Goldenberg N.M., Steinberg B.E. Surface charge: a keydeterminant of protein localization and function . CancerRes. 2010. 70, N 4. P.1277-1280.
CrossRef
PubMed
- James A.M. Molecular aspects of biological surfaces. Chem. Soc. Rev. 1979. 8, N 3. P. 389-418.
CrossRef
- Kruger R.F., Mayer G.D. Tilorone hydrochloride: anorally active antiviral agent . Science. 1970. 169,N 951. P.1213-1214.
CrossRef
- Latorre R., Labarca P., Naranjo D. Surface charge effectson ion conduction in ion channels . Methods Enzymol. 1992. 207. P.471-501.
CrossRef
- Levin R.H.Albrecht W.L. Tilorone and related bis-basicsubstituted polycyclic aromatic and heteroaromatic compounds. Prog. Med. Chem. 1981. N 18. P. 135-190.
CrossRef
- Maher P. Singer S.J. Structural changes in membranesproduced by the binding of small amphiphilic molecules. Biochemistry. 1984. 23, N 2. P. 232-240.
CrossRef
PubMed
- Mironov S.L., Dolgaya E.V. Surface charge of mammalianneurones as revealed by microelectrophoresis . J. Memb.Biol. 1985. 86, N 2. P. 197-202.
CrossRef
PubMed
- Prokopek M. The tilorone-induced mucopolysaccharidosisin rats: Biochemical investigations . Viochem. Pharmacol.1991. 42, N 11. P. 2187-2191.
CrossRef
- Ratan R.R., Siddiq A., Aminova L., Langley B., McConoughey S., Karpisheva K., Lee H.H., Carmichael T., H., Coppola G., Geschwind D.H., Hoke A., Smirnova N., Rink C., Roy S., Sen C., Beattie M.S., Hart O.V., Grumet M., Sun D., Freeman R.S., Semenza G.L., Gazaryan I. Small molecule activation of adaptive gene expression: tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injury . Ann. NY Acad. Sci. 2008. 1147 P. 383-394.
CrossRef
PubMed PubMedCentral
|